about
17beta-Estradiol responsiveness of MCF-7 laboratory strains is dependent on an autocrine signal activating the IGF type I receptorSuramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expressionFrontiers of Ovarian Cancer Therapy.Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Suramin in advanced platinum-resistant ovarian cancer.
@en
Suramin in advanced platinum-resistant ovarian cancer.
@nl
type
label
Suramin in advanced platinum-resistant ovarian cancer.
@en
Suramin in advanced platinum-resistant ovarian cancer.
@nl
prefLabel
Suramin in advanced platinum-resistant ovarian cancer.
@en
Suramin in advanced platinum-resistant ovarian cancer.
@nl
P2093
P1476
Suramin in advanced platinum-resistant ovarian cancer.
@en
P2093
F Bostick-Bruton
M R Cooper
R V LaRocca
P304
P356
10.1016/0959-8049(92)90135-O
P577
1992-01-01T00:00:00Z